Allows users to study prognostic properties of miRNAs in several cancer types, using publicly available data. We have compiled data from Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA), to create this tool. PROGmiR can be used to study overall survival implications for approximately 1050 human miRNAs in 16 major cancer types.
Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN, USA; Departments of Surgery, Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA
PROGmiR funding source(s)
This study was partly supported by IUPUI Breast Cancer Signature Center and Susan G. Komen for the Cure grant SAC110025.